While the association of KRAS mutations with poor prognosis may not be unique to SHCs (29), the occurrence of KRAS mutation may induce sarcomatoid phenotype (30) and indicate poor prognosis in cancers with sarcomatoid component (23). This evidence concerns the gene KRAS and cancer.